If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...
New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
The conversation surrounding health care reform has intensified in recent years, revealing deep divides in how we view personal responsibility, government intervention and public health ...